title: Emergent transcatheter mitral valve-in-valve implantation in a patient with cardiogenic shock secondary to a failed mitral bioprosthesis.
abstract: Transcatheter valve-in-valve (VIV) implantation is emerging as a therapeutic option for treatment of failed bioprosthesis in patients that are deemed high-risk or inoperable for redo-valve replacement. It can be carried out in suitable bioprosthetic valves in any position and usually performed as an elective or semi-elective procedure. Here, we report a case of emergent transcatheter VIV implantation in a failed mitral bioprosthesis in a critically ill patient with cardiogenic shock. We conclude that transcatheter VIV implantation may also be an option for critically ill patients with failing bioprosthesis. © 2015 Wiley Periodicals, Inc.
authors.affiliation: Division of Cardiology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: Oluseun
authors.initials: O
authors.lastname: Alli
authors.affiliation: Division of Cardiology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: Oscar
authors.initials: O
authors.lastname: Booker
authors.affiliation: Department of Cardiovascular Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: James
authors.initials: J
authors.lastname: Davies
keywords: mitral valve disease; percutaneous intervention; structural heart disease intervention